Literature DB >> 33861386

In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.

Jayakanthan Kabeerdoss1, Pulukool Sandhya1,2, Biji T Kurien3,4,5, Robert Hal Scofield3,4,5, Debashish Danda6.   

Abstract

Curcumin reduces disease severity and ameliorates lupus-like/Sjögren's Syndrome-like disease in mice model. The immunological basis of these effects is largely unknown. This study examined the effects of curcumin on pro-inflammatory cytokines secreted by minor salivary glands in patients with primary Sjögren's syndrome (pSS). Minor salivary gland (MSG) tissue samples were collected from patients undergoing biopsy for suspected pSS. The tissues were treated with phytohemagglutinin (PHA) alone as well as PHA with curcumin (30 μM) and cultured in RPMI 1640 medium for 48 h at 37 °C in CO2 incubator. After the incubation period, culture supernatant and tissues were stored in the freezer (-80 °C). IL-6 levels were measured in supernatant by ELISA kit. Gene expressions of pro-inflammatory cytokines, namely IL-6, IL-8, TNF-α, IL-1β, IL-4, IL-10, IL-17, IL-21, and IFN-γ, were measured by qPCR. IL-6 secretion levels and gene expressions were compared statistically between groups by Student's t test. Forty-seven patients were screened. Eight patients satisfied ACR/EULAR criteria for pSS. Seven patients with absent glandular inflammation and negative serology constituted sicca controls. These 15 subjects were included in final analysis. In pSS group, but not in controls, median IL-6 levels in supernatant were less in curcumin-treated as compared to PHA-alone subset [5.5 (0.7-13.34) vs 18.3 (12-32) ng/ml; p = 0.0156]. mRNA expression levels of IL-6 were also lower in curcumin-treated samples as compared to PHA alone, when cases and controls were analyzed together as well as in cases alone (p = 0.0009 and p = 0.0078, respectively); however, mRNA expression of IL-1β was lower in curcumin-treated samples as compared to PHA alone, only when cases and controls were analyzed together (p = 0.0215). There was no difference in other cytokine gene expression levels between the subsets under the in-vitro experimental conditions. In conclusion, curcumin reduced mRNA expression as well as secretion of IL-6 levels by salivary gland tissue of patients with pSS. Curcumin also suppressed PHA-induced mRNA expression levels of IL-6 and IL-1β in MSG tissue of patients with pSS and controls when analyzed together as a combined group.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Curcumin; Cytokines; Labial salivary gland; Sjogren’s syndrome

Mesh:

Substances:

Year:  2021        PMID: 33861386     DOI: 10.1007/s00296-021-04859-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

Review 1.  Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Giuseppe Derosa; Pamela Maffioli; Luis E Simental-Mendía; Simona Bo; Amirhossein Sahebkar
Journal:  Pharmacol Res       Date:  2016-07-05       Impact factor: 7.658

2.  Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.

Authors:  J M van Woerkom; A A Kruize; M J G Wenting-van Wijk; E Knol; I C Bihari; J W G Jacobs; J W J Bijlsma; F P J G Lafeber; J A G van Roon
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

3.  Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease.

Authors:  Jenny Epstein; Guillermo Docena; Thomas T MacDonald; Ian R Sanderson
Journal:  Br J Nutr       Date:  2009-11-02       Impact factor: 3.718

4.  Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort.

Authors:  Gabriel Maciel; Cynthia S Crowson; Eric L Matteson; Divi Cornec
Journal:  Mayo Clin Proc       Date:  2017-05       Impact factor: 7.616

5.  Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.

Authors:  R I Fox; H I Kang; D Ando; J Abrams; E Pisa
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

6.  Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations.

Authors:  Aigli G Vakrakou; Sorina Boiu; Panayiotis D Ziakas; Evangelia Xingi; Haralabia Boleti; Menelaos N Manoussakis
Journal:  J Autoimmun       Date:  2018-03-16       Impact factor: 7.094

7.  2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.

Authors:  Caroline H Shiboski; Stephen C Shiboski; Raphaèle Seror; Lindsey A Criswell; Marc Labetoulle; Thomas M Lietman; Astrid Rasmussen; Hal Scofield; Claudio Vitali; Simon J Bowman; Xavier Mariette
Journal:  Arthritis Rheumatol       Date:  2016-10-26       Impact factor: 10.995

8.  Functional effects of proinflammatory factors present in Sjögren's syndrome salivary microenvironment in an in vitro model of human salivary gland.

Authors:  Mayte Arce-Franco; María Dominguez-Luis; Martina K Pec; Carlos Martínez-Gimeno; Pablo Miranda; Diego Alvarez de la Rosa; Teresa Giraldez; José María García-Verdugo; José David Machado; Federico Díaz-González
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

9.  Skewed production of IL-6 and TGFβ by cultured salivary gland epithelial cells from patients with Sjögren's syndrome.

Authors:  Takafumi Kawanami; Toshioki Sawaki; Tomoyuki Sakai; Miyuki Miki; Haruka Iwao; Akio Nakajima; Takuji Nakamura; Tomomi Sato; Yoshimasa Fujita; Masao Tanaka; Yasufumi Masaki; Toshihiro Fukushima; Yuko Hirose; Makoto Taniguchi; Naotoshi Sugimoto; Toshiro Okazaki; Hisanori Umehara
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

10.  Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lpr mice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment.

Authors:  Biji T Kurien; Valerie M Harris; Syed M S Quadri; Patricia Coutinho-de Souza; Joshua Cavett; Amanda Moyer; Bilal Ittiq; Angela Metcalf; Husayn F Ramji; Dat Truong; Ramesh Kumar; Kristi A Koelsch; Mike Centola; Adam Payne; Debashish Danda; R Hal Scofield
Journal:  Lupus Sci Med       Date:  2015-09-08
View more
  1 in total

1.  Fecal S100A12 in Takayasu arteritis predicts disease activity and intestinal involvement.

Authors:  Simsek Cem; Armagan Berkan; Sari Alper; Emet Abdulsamer; Kilic Levent; Akdogan Ali
Journal:  Rheumatol Int       Date:  2021-09-12       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.